BensaAPrevitaliDSangiorgioABoffaASalernoMFilardoG.PRP injections for the treatment of knee osteoarthritis: the improvement is clinically significant and influenced by platelet concentration: a meta‑analysis of randomized controlled trials. Am J Sports Med. 2025;53(3):745-754.
2.
BoffaAAndrioloLFranceschiniM, et al. Minimal clinically important difference and Patient Acceptable Symptom State in patients with knee osteoarthritis treated with PRP injection. Orthop J Sports Med. 2021;9(10):23259671211026242.
3.
BoffaADe MarzianiLAndrioloL, et al. Influence of platelet concentration on the clinical outcome of platelet‑rich plasma injections in knee osteoarthritis. Am J Sports Med. 2024;52(13):3223-3231.
4.
Di MartinoABoffaAAndrioloL, et al. Leukocyte-rich versus leukocyte‑poor platelet-rich plasma for the treatment of knee osteoarthritis: a double‑blind randomized trial. Am J Sports Med. 2022;50(3):609-617.
5.
FranceschiniMBoffaADi MartinoA, et al. The minimal clinically important difference changes greatly based on the patient’s baseline clinical status. J Exp Orthop. 2025;12(1):e70137.
6.
FranceschiniMBoffaAPignottiEAndrioloLZaffagniniSFilardoG.The minimal clinically important difference changes greatly based on the different calculation methods. Am J Sports Med. 2023;51(4):1067-1073.
7.
RomandiniIBoffaADi MartinoA, et al. Leukocytes do not influence the safety and efficacy of platelet‑rich plasma injections for the treatment of knee osteoarthritis: a double‑blind randomized controlled trial. Am J Sports Med. 2024;52(13):3212-3222.
